Ardis Moe is an Infectious Disease physician affiliated with University of California, Los Angeles. OpenAlex indexes 22 publications with 747 citations (h-index 15); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1399 Roxbury Dr
100
Los Angeles, CA 900354709
Telephone
310-557-1891Registry record last updated 2 Oct 2012.
Clinical trials
- A Study Comparing Long-acting Methylphenidate (ConcertaTM) vs. Placebo in the Treatment of Memory Loss Due to HIV
Sponsor: University of California, Los Angeles
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year202541 payments
- Gilead Sciences, Inc.Program year202524 payments
- ABBVIE INC.Program year202510 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
30.8%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor6.4%Tivicay43%Isentress22%Dovato17%Cabenuva11%Juluca7%Part D<11 patientsHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor4.4%Descovy47%Triumeq25%Abacavir-Lamivudine16%Abacavir8%Zidovudine5%Part D<11 patients+ 17 more classes in this area
Cardiovascular
17.5%Statin5.2%Atorvastatin Calcium66%Rosuvastatin Calcium18%Pravastatin Sodium16%Part D≥70 patientsAngiotensin receptor blocker (ARB)3.2%Losartan Potassium75%Losartan-Hydrochlorothiazide18%Olmesartan Medoxomil4%Telmisartan4%Part D<11 patients+ 16 more classes in this area
Nervous system
16.4%Gabapentinoids3%Gabapentin57%Pregabalin43%Part D≥26 patientsSSRI2.3%Trazodone Hcl36%Citalopram Hbr21%Sertraline Hcl21%Escitalopram Oxalate11%Fluoxetine Hcl11%Part D<11 patients+ 20 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1998–2010 per NIH RePORTER. The latest:
- A PHASE IIIB, RANDOMIZED, TRIAL OF OPEN-LABEL EFAVIRENZ OR ATAZANAVIR WITH RI
University of California Los Angeles
FY2010$134,498M01RR000865 - PHASE II, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF MINOCYCLINE IN T
University of California Los Angeles
FY2010$68,742M01RR000865 - A PHASE II STUDY TO EVALUATE THE IMMUNOGENICITY AND SAFETY OF A QUADRIVALENT HUM
University of California Los Angeles
FY2010$5,274M01RR000865
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 27 Association of anal dysplasia with cervical dysplasia and high-risk HPV subtypes in women
Gynecologic Oncology Reports
2023 - Race/Ethnicity and Protease Inhibitor Use Influence Plasma Tenofovir Exposure in Adults Living with HIV-1 in AIDS Clinical Trials Group Study A5202
Antimicrobial Agents and Chemotherapy
2019 - Low Levels of Endothelial Progenitor Cells and Their Association with Systemic Inflammation and Monocyte Activation in Older HIV-Infected Men
AIDS Research and Human Retroviruses
2017 - Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence
Drug and Alcohol Dependence
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”